Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

NEW STOCK SYMBOL FOR APPLIED MICRO

Oct. 9, 1991

HIGH COURT REJECTS GI'S EPO PATENT APPEAL

Oct. 8, 1991

GLYCOMED TO FILE 2 MILLION-SHARE OFFERING

Oct. 8, 1991

ECOGEN SIGNS DISTRIBUTION DEAL

Oct. 8, 1991

REPLIGEN GETS PATENT RIGHTS FOR ANTIBODIES

Oct. 8, 1991

ONCOGENE COMPLETES ACQUISITION

Oct. 8, 1991

Biogen R&D Agreement for Hirulog

Oct. 8, 1991

APPOINTMENTS AND ADVANCEMENTS

Oct. 7, 1991

MID-ATLANTIC VENTURE FAIR

Oct. 7, 1991

ALFACELL EXPANDS ONCONASE TRIALS

Oct. 7, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...